Gritstone bio
After emerging from Chapter 11 bankruptcy, hiring a new management team and a dedicated new team of scientists, Gritstone bio is changing its name to Nexoplex bio. This change is reflective of new energy and focus on the development of our portfolio of bispecific antibodies. Watch for more exciting updates as our team progresses our portfolio of bispecifics to provide treatments for unmet needs in oncology.
Basic Information
- Category: Vaccines
- Founded: 2015
- Headquarters: Emeryville, CA
- Website: gritstonebio.com
Documented Facts
- Email: info@nexoplexbio.com (No linked source recorded for this statement.)
Evidence and Sources
- Gritstone bio — Official Site (official)
- Gritstone bio on linkedin (social)
Citation Guidance
Explore Vaccines profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Gritstone bio.
- Canonical profile: https://brandsource.ai/brands/gritstone-bio
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/gritstone-bio/json-ld
- Citation profile API: https://brandsource.ai/api/brands/gritstone-bio/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (81/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2025-10-28T20:51:26.022Z
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
After emerging from Chapter 11 bankruptcy, hiring a new management team and a dedicated new team of scientists, Gritstone bio is changing its name to Nexoplex bio. This change is reflective of new energy and focus on the development of our portfolio of bispecific antibodies. Watch for more exciting updates as our team progresses our portfolio of bispecifics to provide treatments for unmet needs in oncology.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 1 supporting source linked.
- 1 structured fact available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.